Abstract
Nuclear imaging is assuming an increasing role in the management of patients with cancer. A variety of new radiopharmaceuticals, several antibody or peptide based, as well as innovative uses of existing radiopharmaceuticals, mean that most nuclear medicine departments equipped with standard imaging devices can image the single photon imaging agents without difficulty.
| Original language | English |
|---|---|
| Pages (from-to) | 341-360 |
| Number of pages | 20 |
| Journal | Primary Care - Clinics in Office Practice |
| Volume | 25 |
| Issue number | 2 |
| DOIs | |
| State | Published - 1998 |